Grünenthal Acquires Adhesys Medical
Baker McKenzie advised the Grünenthal Gruppe on its acquisition of Adhesys Medical GmbH and its US subsidiary Adhesys Medical Inc. Adhesys Medical is a medical device startup company focused on the development of adhesives used in surgery. The acquisition of Adhesys Medical and its highly innovative pipeline of surgical sealants, together with the underlying technology platform, allows Grünenthal to tap into the global development and marketing rights. The transaction was signed and closed simultaneously.
Baker McKenzie comprehensively advised Grünenthal on legal matters with an international team from Germany and the US. The transaction was highly complex due to the number of sellers and the parallel acquisition of the shares in both Adhesys Medical GmbH and its US subsidiary Adhesys Medical Inc..
"With this transaction our client continues its strategy to increase and diversify its portfolio. With our cross-border strength we were in the position to support our client efficiently and successfully", comments Dr. Ingo Strauss, Corporate/M&A-partner at Baker McKenzie, who led the transaction.
Grünenthal is an independent, family-owned pharmaceutical company headquartered in Aachen, Germany. The company is present in 32 countries with affiliates in Europe, Latin America and the US. Its products are sold in more than 155 countries and approx. 5,500 employees work for the Grünenthal Group worldwide. In 2016, Grünenthal achieved revenues of approximately 1.4 billion euros.
Baker McKenzie regularly advises clients on cross-border transactions and reorganizations. Most recently the team advised Flowserve Corporation on the sale of the Gestra-Gruppe, Uniwheels in the sale to Superior Industries, ZF Friedrichshafen AG on the sale of the Cherry Group, the owners of Fragrance Resources on the sale of its fragrance business to International Flavors & Fragrances, Inc., GFKL on the acquisition of Tesch Group, CORESTATE on its acquisition of Hannover Leasing, Heraeus Group on the sale of the global high-performance target materials business to the US-based Materion Group, MAGNA International on its acquisition of the Böddecker & Co. GmbH & Co. KG, Dassault Systèmes on the acquisition of the CST group, Sulzer on the takeover of the GEKA group of 3i, Deutsche Beteiligungs AG on its participation in Reinhold & Mahla-Group, RWE and E.ON on the sale of their shares in the Luxembourg energy supplier Enovos, HITACHI Koki on the acquisition of Metabo AG and Barry-Wehmiller group on the acquisition of the operations of Winkler+Dünnebier GmbH.
Legal advisors to Grünenthal:
Lead: Corporate/M&A: Dr. Ingo Strauss (partner, Düsseldorf), Dr. Heiko Gotsche (partner, Düsseldorf)
Team: Corporate/M&A: Jana Upschulte (associate, Düsseldorf), Cosima König (associate, Düsseldorf)
Pharmaceuticals: Dr. Thilo Räpple (partner, Frankfurt), Dr. Martin Altschwager (associate, Frankfurt)
IP: Dr. Michael Fammler (partner, Frankfurt), Philip Schmitz (associate, Munich)
Employment: Dr. Hagen Köckeritz (partner, Frankfurt), Sarah Wekel (associate, Frankfurt)
Tax: Christoph Becker (partner, Frankfurt)
Public Law: Dr. Janet Kerstin Butler (counsel, Berlin)
USA: Alan F. Zoccolillo (partner, New York), Lelise Gobena (associate, New York), Neil O'Flaherty (partner, Washington)
Inhouse Grünenthal: Marcus Heppner (Group General Counsel)